跳至主要内容
临床试验/IRCT20190427043389N4
IRCT20190427043389N4尚未招募3 期

The effectiveness of the combination of Memantine and Betahistine on insomnia severity, quality of life and severity of symptoms in people with primary tinnitus

Zanjan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Having primary tinnitus for more than 3 months
  • Willingness and interest to participate in the study
  • Having moderate intensity of insomnia (scoring more than 15 based on the ISI Insomnia Severity Questionnaire)

排除标准

  • Tinnitus due to anatomical disease
  • Previous use of memantine
  • History of high blood pressure
  • Suffering from chronic and debilitating diseases as diagnosed by the attending physician
  • Known mental illness
  • Concomitant use of medications that interact with memantine
  • contraindication of memantine by the doctors diagnosis

研究者

相似试验